The first two are carbohydrate degrading enzymes; thus, they can retard the absorption of glucose into the bloodstream, thereby controlling diabetes, while DPP-IV inhibition promotes the release of insulin, resulting in low blood glucose levels. This evidence concerns the gene INS and diabetes mellitus.